- Home
- SGBX vs GTBP Comparison
SGBX vs GTBP Comparison
Compare SGBX & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGBX
- GTBP
- Stock Information
- Founded
- SGBX 2007
- GTBP 1965
- Country
- SGBX United States
- GTBP United States
- Employees
- SGBX N/A
- GTBP 2
- Industry
- SGBX RETAIL: Building Materials
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- SGBX Consumer Discretionary
- GTBP Health Care
- Exchange
- SGBX Nasdaq
- GTBP Nasdaq
- Market Cap
- SGBX 4.2M
- GTBP 4.9M
- IPO Year
- SGBX 2017
- GTBP N/A
- Fundamental
- Price
- SGBX $0.68
- GTBP $2.24
- Analyst Decision
- SGBX
- GTBP Strong Buy
- Analyst Count
- SGBX 0
- GTBP 1
- Target Price
- SGBX N/A
- GTBP $11.00
- AVG Volume (30 Days)
- SGBX 11.8M
- GTBP 244.8K
- Earning Date
- SGBX 11-27-2024
- GTBP 03-25-2025
- Dividend Yield
- SGBX N/A
- GTBP N/A
- EPS Growth
- SGBX N/A
- GTBP N/A
- EPS
- SGBX N/A
- GTBP N/A
- Revenue
- SGBX $5,889,321.00
- GTBP N/A
- Revenue This Year
- SGBX $273.79
- GTBP N/A
- Revenue Next Year
- SGBX $39.31
- GTBP N/A
- P/E Ratio
- SGBX N/A
- GTBP N/A
- Revenue Growth
- SGBX N/A
- GTBP N/A
- 52 Week Low
- SGBX $0.38
- GTBP $1.72
- 52 Week High
- SGBX $9.80
- GTBP $10.66
- Technical
- Relative Strength Index (RSI)
- SGBX 46.97
- GTBP 46.09
- Support Level
- SGBX $0.61
- GTBP $2.10
- Resistance Level
- SGBX $0.75
- GTBP $2.27
- Average True Range (ATR)
- SGBX 0.13
- GTBP 0.20
- MACD
- SGBX -0.03
- GTBP 0.00
- Stochastic Oscillator
- SGBX 17.87
- GTBP 56.00
About SGBX Safe & Green Holdings Corp.
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.